Fani Karagianni

4PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 28, 2024
Combination of JAKi and HDACi Exerts Antiangiogenic Potential in Cutaneous T-Cell Lymphoma.

Fani Karagianni, Christina Piperi, Sara Valero-Diaz

|Feb 25, 2022
Combination of Resminostat with Ruxolitinib Exerts Antitumor Effects in the Chick Embryo Chorioallantoic Membrane Model for Cutaneous T Cell Lymphoma.

Fani Karagianni, Christina Piperi, Berta Casar

|Feb 15, 2022
Predominant Role of mTOR Signaling in Skin Diseases with Therapeutic Potential.

Fani Karagianni, Antreas Pavlidis, Lina S Malakou

|Mar 11, 2021
Ruxolitinib with resminostat exert synergistic antitumor effects in Cutaneous T-cell Lymphoma.

Fani Karagianni, Christina Piperi, Vassiliki Mpakou

Pageof 1

Frequent Collaborators

3 joint publications

Christina Piperi

2 joint publications

Berta Casar

1 joint publications

Antreas Pavlidis

1 joint publications

Rocío García-Gómez